2seventy suffers sales slump on high production charges for BMS-partnered CAR-T med Abecma
If you’re curious about the pitfalls of CAR-T drug commercialization, look no further than Bristol Myers Squibb’s Abecma partner 2seventy bio.
After reporting a s...